Navigation Links
Cellectis Publishes Its Financial Statement for the First Half of 2010
Date:10/15/2010

PARIS, Oct. 15 /PRNewswire-FirstCall/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.

During the first half of 2010, Cellectis entered into a number of important new agreements (with BASF Plant Science, Boehringer Ingelheim), published data in a peer-reviewed journal on the therapeutic potential of meganucleases in Duchenne muscular dystrophy and launched Cellectis plant sciences. Cellectis was also granted the INPI National Innovation Award for its intellectual property strategy. In addition, Cellectis' research and production tools subsidiary, Cellectis bioresearch, entered into a development and commercial manufacturing agreement with Lonza that establishes a presence for Cellectis in the bioproduction market.

"The figures for this half year reflect our growth strategy," said Andre Choulika, CEO at Cellectis. "Cellectis' staff has doubled in a year and comprises 130 people today, in all entities, compared to 65 in July 2009. This has allowed us to strengthen our position, in all aspects of our business, with highly competent and committed people."

"The capital increase that was made in October 2009 allows us to finance this rapid growth and support our ambitious external growth strategy," added Marc Le Bozec, CFO at Cellectis.

The slide show presenting the half-year results in details is available on http://www.cellectis.com/investors/accounts-and-reports Simplified Income Statement – Financial items are presented according to IFRSFigures in thousands of euros

2010
first 6 months2009
first  6 monthsSales

6 2505 020Other revenue
'/>"/>

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearchs cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery
2. Cellectis Bioresearch and Cedarlane Join Forces for the Distribution of cGPS® and cGPS® Custom Kits in Canada
3. Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India
4. Cellectis bioresearch Announces Establishment of Subsidiary in the US
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
8. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
9. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
(Date:8/27/2014)... , Aug. 27, 2014 ... research report is available in its ... for Application and Approval of Imported ... Practices (2014 Edition) ... Now, Chinese regulations on medical ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
(Date:8/27/2014)... Houston, TX (PRWEB) August 27, 2014 ... The reality is that depression has a mortality ... those with bi-polar disorder is slightly less, though it's ... of roughly 7%. In order to properly treat ... schizophrenia, and bi-polar, medication must be taken as directed. ...
(Date:8/27/2014)... Illinois (PRWEB) August 27, 2014 Aspirus ... project in the US with Buzz™ Digital O.R. at ... foundation of all 13 new operating rooms will be ... and management. This integrative system supports planning, navigation, imaging ... an advanced fusion of intuitive software and hardware all ...
(Date:8/27/2014)... of the leading purveyors of real and synthetic hair wigs, hair ... its products, for the coming Labor Day. , People searching for ... hair products in two ways: when they spend more than $89 ... LABOR10; while when they spend more than $299, they can save ... code is needed when securely checkout, there are about 50 products ...
(Date:8/27/2014)... is the second leading cause of cancer-associated death ... the difficulty in treating this cancer using conventional ... etoposide or combinations therein. This may be attributed ... to reach in a sufficient concentration in the ... harmful to the rest of the body. Considering ...
(Date:8/27/2014)... which repel water and oil and are persistent ... processing. These characteristics have made the fluorochemicals useful ... for food paper and board. , The problem ... break down and accumulate in both humans and ... harmful health effects, such as cancer, increased cholesterol ...
Breaking Medicine News(10 mins):Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 3Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3
... new findings don,t apply to men , , MONDAY, Aug. ... against skin cancer and may actually boost the risk, ... study. , "Taking into consideration our results, we are ... in sun-seekers and people wanting to look tanned [using ...
... A patients expectations about the side effects of ... other side effects. Worries about severe allergic reactions to ... recent study from the Lineberger Comprehensive Cancer Center at ... Vanderbilt-Ingram Comprehensive Cancer Center and the Sarah Canon Cancer ...
... researchers say , , MONDAY, Aug. 20 (HealthDay News) -- ... C. Hurlbert wondered why all the products aimed at her ... professor of visual neuroscience at Newcastle University in England, Hurlbert ... whether girls really do prefer pink. The answer, as outlined ...
... Findings probably apply to males of other ethnicities, researchers say ... increases the risk of stroke in Chinese men, a new ... were 40 and older and had no history of stroke ... the men was conducted between 1999 and 2000, researchers found ...
... 20, 2007 - Lissamine green sounds like the latest ... something you would want to get in your eyes. ... staining patterns that are key to diagnosing dry eye ... for treating the potentially sight-stealing disease, new research at ...
... between brain cells along hairlike extensions called axons. For ... just transmit information they can turn the signal ... finding may help scientists develop treatments for psychiatric disorders ... thought that different parts of the brain do not ...
Cached Medicine News:Health News:Antioxidant Supplements May Raise Women's Skin Cancer Risk 2Health News:Antioxidant Supplements May Raise Women's Skin Cancer Risk 3Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 2Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 3Health News:Girls Really Do Prefer Pink 2Health News:Heavy Drinking Boosts Stroke Risk for Chinese Men 2Health News:Eye-staining technique offers early detection for dry eye syndrome 2Health News:Eye-staining technique offers early detection for dry eye syndrome 3Health News:Brain cells work differently than previously thought 2
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
The XCHO method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in serum and plasma....
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: